Serum
soluble CD25 levels were associated with prognosis of children with
Langerhans cell histiocytosis
Zi-Jing Zhao1,2,3,4, Hong-Yun
Lian2,3,4 , Wei-Jing Li1,2,3,4, Qing
Zhang1,2,3,4, Hong-Hao Ma2,3,4, Dong
Wang2,3,4, Yun-Ze Zhao2,3,4, Ting
Zhu1,2,3,4, Hua-Lin Li1,2,3,4,
Xiao-Tong Huang1,2,3,4, Tian-You
Wang1,2,3,4, Rui Zhang2,3,4*, Lei
Cui1,2,3,4*, Zhi-Gang Li1,2,3,4*
1Hematologic Diseases Laboratory, Beijing Pediatric
Research Institute, Beijing Children’s Hospital, Capital Medical
University, National Center for Children’s Health, Beijing, China
2Beijing Key Laboratory of Pediatric
Hematology-Oncology, Hematology Center, Beijing Children’s Hospital,
Capital Medical University, National Center for Children’s Health,
Beijing, China
3National Key Discipline of Pediatrics, Capital
Medical University, Beijing, China
4Key Laboratory of Major Diseases in Children,
Ministry of Education, Beijing, China
*Correspondence to
Lei Cui, PhD, Beijing Children’s Hospital, 56 Nanlishi Road, Xicheng
District, Beijing 100045, China. Tel: +86 1059617010. Email:
cuileilsh@163.com. ORCID: https://orcid.org/0000-0002-7611-1431;
Zhi-Gang Li, PhD, Beijing Children’s Hospital, 56 Nan Lishi Road,
Xicheng District, Beijing 100045, China. Tel: +86 1059617010. E-mail:
ericlzg70@hotmail.com. ORCID: https://orcid.org/0000-0001-5334-9706;
Rui Zhang, MD, Beijing Children’s Hospital, 56 Nan Lishi Road, Xicheng
District, Beijing 100045, China. Tel: +86 1059612261. E-mail:
ruizh1973@126.com. ORCID:https://orcid.org/0000-0002-3727-1192.
Text word count: 2990
Abstract word count: 208
Brief running title: sCD25 in pediatric LCH
Key words: Langerhans cell histiocytosis, sCD25, prognosis, relapse
Tables: 1
Figures: 4